AustralianSuper Pty Ltd

Position in ABBV — AbbVie Inc.

CIK 1694164 MELBOURNE, C3

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$107,364,219

+$62,963,853 QoQ

Shares Held

426,658

+109.0% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#245

of 4,167 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AustralianSuper Pty Ltd holds $1,190,287,072 across 9 Drug Manufacturers - General names. ABBV ranks #5 (9.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	469,702	$563,374,716
2	GILD	Gilead Sciences, Inc.	1,271,457	$160,635,877
3	BIIB	Biogen Inc.	672,723	$145,348,531
4	BMY	Bristol Myers Squibb Co	2,433,354	$140,209,857
5	ABBV	AbbVie Inc. This page	426,658	$107,364,219
6	JNJ	Johnson & Johnson	152,900	$38,832,013
7	PFE	Pfizer Inc	968,550	$23,322,684
8	MRK	Merck & Co., Inc.	77,831	$10,001,283

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$107,364,219	426,658	+109.0%	Shares	Sole	2026-08-12
2026-03-31	$44,400,366	204,149	-6.7%	Shares	Sole	2026-05-07
2025-12-31	$49,969,163	218,693	+1.4%	Shares	Sole	2026-02-05
2025-09-30	$49,925,349	215,623	+2717.9%	Shares	Sole	2025-11-12
2025-06-30	$1,420,364	7,652	+0.2%	Shares	Sole	2025-08-01
2025-03-31	$1,599,475	7,634	-15.9%	Shares	Sole	2025-05-05
2024-06-30	$1,557,058	9,078	+8.4%	Shares	Sole	2024-07-26
2024-03-31	$1,524,359	8,371	-99.0%	Shares	Sole	2024-04-26
2023-12-31	$128,417,595	828,661	+8706.2%	Shares	Sole	2024-01-16
2023-09-30	$1,402,654	9,410	—	Shares	Sole	2023-10-27
No filing history on record for this holder in this stock.